MedRegen, LLC
6Patents
6Active
6Granted
43Portfolio score
Filing activity: Dec 10, 2010 → Nov 10, 2021
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10420751B2 | Methods of treating inflammatory bowel disease with AMD3100 and tacrolimus | Human Necessities | 2 | Active |
| US11291657B2 | Methods of treating inflammatory bowel disease with AMD3100 and Tacrolimus | Human Necessities | 1 | Active |
| US10813917B2 | Treatment methods utilizing stem cell mobilizers and immunosuppressive agents | Human Necessities | 0 | Active |
| US10945993B2 | Methods of recruiting SDF-producing macrophages | Human Necessities | 0 | Active |
| US12048687B2 | Methods of recruiting SDF-producing macrophages | Human Necessities | 0 | Active |
| US12115149B2 | Formulations, methods, kits, and dosage forms | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.